nach oben

Erschienen in:

22.09.2020 | Original Article

Patient characteristics associated with sleep disturbance in breast cancer survivors

verfasst von: Chelsea G. Ratcliff, Stephanie G. Zepeda, Martica H. Hall, Emily A. Tullos, Shaelyn Fowler, Alejandro Chaoul, Amy Spelman, Banu Arun, Lorenzo Cohen

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Disturbed sleep is common among breast cancer survivors. Identifying patients at risk for disturbed sleep and its sequelae will aid in improving screening and intervention strategies to improve sleep and cancer-related quality of life (QOL).

Methods

Women with stages I–III breast cancer undergoing neoadjuvant or adjuvant chemotherapy (N = 415) reported subjectively assessed sleep quality (PSQI) and actigraphy-assessed wake after sleep onset (AAS-WASO), total sleep time (AAS-TST), and sleep efficiency (AAS-SE), sociodemographic, and clinical characteristics and completed questionnaires assessing physical and mental health QOL at study entry and 3, 6, 12, and 15 months later.

Results

Being from a racially/ethnically underserved population was associated with poorer sleep in all indices (p’s < .04). Lower income was associated with poorer subjective sleep and greater AAS-WASO (p’s < .02). BMI was associated with lower AAS-SE (p < .001). Baseline subjective sleep complaints were positively associated with depression, fatigue, and health-related QOL and cancer-related symptoms across follow-up (p’s < 0.05). Baseline AAS-WASO was positively associated with anxiety and negatively associated with physical health-related QOL at the 3-month follow-up (p’s < .001). Baseline AAS-WASO and AAS-SE were associated with mental health-related QOL at the 6-month follow-up (p’s < .05).

Conclusions

In keeping with previous health disparity research, racially/ethnically underserved populations, lower household income, and higher BMI were associated with increased risk for disturbed sleep. Sleep disturbance may have long-term effects on multiple aspects of QOL for women undergoing treatment for breast cancer. Results may inform strategies to identify patients at greatest risk for disturbed sleep and its sequelae.

Lowery-Allison AE, Passik SD, Cribbet MR et al (2018) Sleep problems in breast cancer survivors 1-10 years posttreatment. Palliat Support Care 16(3):325–334. https://doi.org/10.1017/S1478951517000311CrossRefPubMed

Vin-Raviv N, Akinyemiju T, Galea S, Bovbjerg D (2018) Sleep disorder diagnoses and clinical outcomes among hospitalized breast cancer patients: a nationwide inpatient sample study. Support Care Cancer 26(6):1833–1840CrossRef

Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L et al (2008) The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psycho-oncology 17(1):9–18CrossRef

Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6(2):97–111CrossRef

Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR et al (2006) Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14(3):201–209CrossRef

Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE et al (2012) The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep 35(2):237–245CrossRef

Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN, Zachariae R (2011) Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manag 42(5):710–720CrossRef

Ratcliff CG, Lam CY, Arun B, Valero V, Cohen L (2014) Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer. Psycho-Oncology 23(11):1220–1228CrossRef

Liu L, Fiorentino L, Rissling M, Natarajan L, Parker BA, Dimsdale JE et al (2013) Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med 11(3):189–206CrossRef

10.

Koopman C, Nouriani B, Erickson V, Anupindi R, Butler LD, Bachmann MH et al (2002) Sleep disturbances in women with metastatic breast cancer. Breast J 8(6):362–370CrossRef

11.

Wright CE, Schnur JB, Montgomery GH, Bovbjerg DH (2010) Psychological factors associated with poor sleep prior to breast surgery: an exploratory study. Behav Med 36(3):85–91CrossRef

12.

Kung P-Y, Chou K-R, Lin K-C, Hsu H-W, Chung M-H (2015) Sleep disturbances in patients with major depressive disorder: incongruence between sleep log and actigraphy. Arch Psychiatr Nurs 29(1):39–42CrossRef

13.

Beck SL, Berger AM, Barsevick AM, Wong B, Stewart KA, Dudley WN (2010) Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer 18(6):679–689CrossRef

14.

Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE et al (2012) A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manag 44(2):215–228CrossRef

15.

Enderlin CA, Coleman EA, Cole C, Richards KC, Kennedy RL, Goodwin JA et al (2011) Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer. Oncol Nurs Forum

16.

Budhrani PH, Lengacher CA, Kip K, Tofthagen C, Jim H (2014) Minority breast cancer survivors: the association between race/ethnicity, objective sleep disturbances, and physical and psychological symptoms. Nurs Res Pract 858403

17.

Durrence HH, Lichstein KL (2006) The sleep of African Americans: a comparative review. Behav Sleep Med 4(1):29–44CrossRef

18.

Aldridge-Gerry A, Zeitzer JM, Palesh OG, Jo B, Nouriani B, Neri E et al (2013) Psychosocial correlates of sleep quality and architecture in women with metastatic breast cancer. Sleep Med 14(11):1178–1186CrossRef

19.

Savard J, Simard S, Blanchet J, Ivers H, Morin CM (2001) Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24(5):583–590CrossRef

20.

Rissling MB, Liu L, Natarajan L, He F, Ancoli-Israel S (2011) Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy. Support Care Cancer 19(8):1107–1115CrossRef

21.

Champion VL, Wagner LI, Monahan PO, Daggy J, Smith L, Cohee A et al (2014) Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer 120(15):2237–2246CrossRef

22.

Tworoger SS, Davis S, Vitiello MV, Lentz MJ, McTiernan A (2005) Factors associated with objective (actigraphic) and subjective sleep quality in young adult women. J Psychosom Res 59(1):11–19CrossRef

23.

Wirth MD, Hébert JR, Hand GA, Youngstedt SD, Hurley TG, Shook RP et al (2015) Association between actigraphic sleep metrics and body composition. Ann Epidemiol 25(10):773–778CrossRef

24.

Chaoul A, Milbury K, Spelman A, Basen-Engquist K, Hall MH, Wei Q et al (2018) Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy. Cancer 124(1):36–45CrossRef

25.

Hall MH (2010) Behavioral medicine and sleep: concepts, measures, and methods. In: Handbook of Behavioral Medicine. Springer, Berlin, pp 749–765CrossRef

26.

Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRef

27.

Blackwell T, Redline S, Ancoli-Israel S, Schneider JL, Surovec S, Johnson NL, Cauley JA, Stone KL, Study of Osteoporotic Fractures Research Group (2008) Comparison of sleep parameters from actigraphy and polysomnography in older women: the SOF study. Sleep 31(2):283–291. https://doi.org/10.1093/sleep/31.2.283CrossRefPubMedPubMedCentral

28.

Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401CrossRef

29.

Spielberger CD (1970) STAI manual for the state-trait anxiety inventory. Self-evaluation questionnaire, pp 1–24

30.

Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186–1196CrossRef

31.

Ware JE, Kosinski M, Dewey JE, Gandek B (2000) SF-36 health survey: manual and interpretation guide: Quality Metric Inc.

32.

Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Annal Acad Med 23(2):129–138

33.

Natale V, Plazzi G, Martoni M (2009) Actigraphy in the assessment of insomnia: a quantitative approach. Sleep 32(6):767–771. https://doi.org/10.1093/sleep/32.6.767CrossRefPubMedPubMedCentral

34.

Hale L, Do DP (2007) Racial differences in self-reports of sleep duration in a population-based study. Sleep 30(9):1096–1103CrossRef

35.

Redline S, Kirchner HL, Quan SF, Gottlieb DJ, Kapur V, Newman A (2004) The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med 164(4):406–418CrossRef

36.

Jehan S, Myers AK, Zizi F, Pandi-Perumal SR, Jean-Louis G, Singh N et al (2018) Sleep health disparity: the putative role of race, ethnicity and socioeconomic status. Sleep Med Disorders Int J 2(5):127

37.

Ellison GT, Smart A, Tutton R, Outram SM, Ashcroft R, Martin P (2007) Racial categories in medicine: a failure of evidence-based practice? PLoS Med 4(9):e287CrossRef

38.

Krueger PM, Reither EN (2015) Mind the gap: race/ethnic and socioeconomic disparities in obesity. Current diabetes reports 15(11):95CrossRef

39.

Vena C, Parker KP, Allen R, Bliwise DL, Jain S, Kimble L (2006) Sleep-wake disturbances and quality of life in patients with advanced lung cancer. Oncology Nursing Forum, Oncology Nursing SocietyCrossRef

40.

Palesh O, Aldridge-Gerry A, Zeitzer JM et al (2014) Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 37(5):837–842. Published 2014 May 1. https://doi.org/10.5665/sleep.3642CrossRefPubMedPubMedCentral

41.

Yennurajalingam S, Tayjasanant S, Balachandran D, Padhye NS, Williams JL, Liu DD et al (2016) Association between daytime activity, fatigue, sleep, anxiety, depression, and symptom burden in advanced cancer patients: a preliminary report. J Palliat Med 19(8):849–856CrossRef

42.

Guzman GG (2017) Household income: 2016: US Department of Commerce, Economics and Statistics Administration.

43.

Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS (2014) Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 32(5):449–457CrossRef

Titel: Patient characteristics associated with sleep disturbance in breast cancer survivors
verfasst von: Chelsea G. Ratcliff
Stephanie G. Zepeda
Martica H. Hall
Emily A. Tullos
Shaelyn Fowler
Alejandro Chaoul
Amy Spelman
Banu Arun
Lorenzo Cohen
Publikationsdatum: 22.09.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 5/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-020-05777-3

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Patient characteristics associated with sleep disturbance in breast cancer survivors

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

FIBCD1 ameliorates weight loss in chemotherapy-induced murine mucositis

The challenge of sustainability in healthcare systems: cost of radiotherapy in the last month of life in an Italian cancer center

The silent transition from curative to palliative treatment: a qualitative study about cancer patients’ perceptions of end-of-life discussions with oncologists

Prospective patient-reported symptom profiles associated with pediatric acute lymphoblastic leukemia relapse

Fertility counseling information adequacy as a moderator of regret among adolescent and young adult breast cancer survivors

Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie